Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evoke Pharma

3.21
-0.2787-7.99%
Post-market: 3.290.0800+2.49%18:04 EDT
Volume:38.43K
Turnover:125.31K
Market Cap:4.77M
PE:-0.77
High:3.57
Open:3.49
Low:3.07
Close:3.49
Loading ...

Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported And Analysts Have Been Cutting Their Estimates

Simply Wall St.
·
16 Mar

Evoke Pharma’s Earnings Call Highlights Revenue Growth and Strategic Partnerships

TIPRANKS
·
15 Mar

Evoke Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
15 Mar

Q4 2024 Evoke Pharma Inc Earnings Call

Thomson Reuters StreetEvents
·
15 Mar

Evoke Pharma Inc (EVOK) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans

GuruFocus.com
·
14 Mar

Evoke Pharma Reports Strong Revenue Growth in 2024

TIPRANKS
·
14 Mar

Evoke Pharma Q4 Sales $3.31M Beat $3.08M Estimate

Benzinga
·
14 Mar

Evoke Pharma Inc: Projects Net Revenue in 2025 of Approximately $16 Mln

THOMSON REUTERS
·
14 Mar

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
14 Mar

Evoke Pharma Inc expected to post a loss of 63 cents a share - Earnings Preview

Reuters
·
12 Mar

Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025

GlobeNewswire
·
06 Mar

Evoke Pharma Appoints Greg Pyszcymuka as Director

TIPRANKS
·
24 Feb

Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors

THOMSON REUTERS
·
24 Feb

Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors

GlobeNewswire
·
24 Feb

Berenberg Bank Reaffirms Their Buy Rating on 888 Holdings (EVOK)

TIPRANKS
·
21 Jan

Here’s Why Evoke Pharma, Inc. (NASDAQ:EVOK) Is Among the Best Diabetes Stocks to Buy Under $10

Insider Monkey
·
06 Jan